不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:An Unexpected Presentation of a Maxillary Non-Hodgkin Lymphoma in an Elderly Hispanic Patient.
An Unexpected Presentation of a Maxillary Non-Hodgkin Lymphoma in an Elderly Hispanic Patient.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
鼻型结外NK/T细胞淋巴瘤(ENKTL)和侵袭性NK细胞白血病在西方国家十分罕见,在美国非霍奇金淋巴瘤中不足1%,在亚洲可达8%。这类疾病具有侵袭性,预后不佳,最佳治疗方案尚不明确。年轻患者曾采用包括培门冬酶在内的联合方案(SMILE)。一名85岁波多黎各裔男性因厌食、鼻出血、眩晕和不自主面部运动就诊。因怀疑半面痉挛,患者接受了注射用A型奥纳肉毒毒素治疗。但CT扫描显示左上颌窦病灶延伸至左侧中鼻甲,活检结果符合ENKTL。我们根据患者年龄和体能状态调整治疗方案,采用吉西他滨-奥沙利铂(Gemox)联合放疗,最终取得完全缓解,且EB病毒DNA滴度持续阴性。ENKTL是一种罕见疾病,本例老年患者最初被误诊;经调整的治疗方案取得了良好应答。
Extranodal NK/T-cell lymphoma (ENKTL), nasal type and aggressive NK cell leukemia are rare in Western World been less than 1% in USA to 8% in Asia among Non-Hodgkin's lymphomas. It is aggressive, with poor outcome and optimal treatment is unclear. A combination therapy that includes Peg-Asparaginase (SMILE) has been employed in young patients. An 85-year-old Puerto Rican male presented with anorexia, epistaxis, vertigo and involuntary facial movements. He was treated with injectable Onabotulinum toxin A due to suspicion of a hemifacial spasm.
However, a CT scan demonstrated a left maxillary sinus lesion extending into the left middle turbinate with biopsy consistent with ENKTL.
We adjusted therapy to patient's age and performance receiving Gemcitabine-Oxaliplatin (Gemox) with radiation obtaining a complete response with persistent negative Epstein Barr DNA titers. ENKTL is a rare disease initially misdiagnosed in our elderly patient, who demonstrated adequate response with a modified therapeutic regime.
MEMBER ACCOUNT
登录成功会直接打开下一页。